Athanasios Tragiannidis Selected Research

Athanasios Tragiannidis Research Topics

Disease

12	Neoplasms (Cancer) 11/2023 - 03/2012
12	Infections 01/2023 - 07/2009
7	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 07/2009
6	Mycoses (Diseases, Fungus) 11/2023 - 07/2009
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 10/2022
5	COVID-19 01/2024 - 06/2022
5	Invasive Fungal Infections 10/2019 - 07/2009
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2024 - 05/2011
4	Lymphoma (Lymphomas) 11/2023 - 03/2021
4	Leukemia 01/2023 - 03/2021
3	Sepsis (Septicemia) 01/2023 - 01/2019
3	Bacteremia 01/2023 - 01/2019
3	Hemorrhage 01/2021 - 05/2011
3	Candidemia 12/2020 - 09/2018
3	Communicable Diseases (Infectious Diseases) 09/2018 - 03/2012
2	Thrombocytopenia (Thrombopenia) 04/2024 - 01/2021
2	Cardiotoxicity 06/2023 - 01/2023
2	Invasive Pulmonary Aspergillosis 01/2023 - 12/2016
2	Aspergillosis 01/2023 - 01/2013
2	Febrile Neutropenia 01/2023 - 02/2017
2	Inflammation (Inflammations) 06/2022 - 04/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 04/2017
2	Biliary Atresia 01/2019 - 01/2018
2	Necrosis 08/2017 - 04/2017
2	Bone Marrow Failure Disorders 02/2017 - 07/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2024
1	Autoimmune Diseases (Autoimmune Disease) 04/2024
1	Osteosarcoma (Osteogenic Sarcoma) 11/2023
1	Hypersensitivity (Allergy) 06/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 10/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022
1	Opportunistic Infections (Opportunistic Infection) 10/2022
1	Hemolysis 01/2022
1	Dysgammaglobulinemia 09/2021

Drug/Important Bio-Agent (IBA)

6	Antifungal AgentsIBA 09/2021 - 07/2009
5	Monoclonal AntibodiesIBA 01/2023 - 04/2017
4	Rituximab (Mabthera)FDA Link 10/2022 - 08/2017
3	Inosine Triphosphate (ITP)IBA 04/2024 - 05/2011
3	AntigensIBA 01/2023 - 03/2021
3	Chimeric Antigen ReceptorsIBA 01/2023 - 03/2021
3	pembrolizumabIBA 10/2022 - 03/2021
3	blinatumomabIBA 10/2022 - 03/2021
3	Inotuzumab OzogamicinIBA 10/2022 - 03/2021
3	liposomal amphotericin B FDA Link 12/2020 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2023
2	MicroRNAs (MicroRNA)IBA 02/2024 - 11/2023
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2023 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 01/2019
2	Voriconazole (Vfend)FDA LinkGeneric 11/2023 - 12/2016
2	Brentuximab VedotinIBA 10/2022 - 03/2021
2	nilotinib FDA Link 10/2022 - 09/2021
2	Imatinib Mesylate (Gleevec)FDA Link 10/2022 - 09/2021
2	Dasatinib (BMS 354825)FDA Link 10/2022 - 09/2021
2	Gemtuzumab (Mylotarg)FDA Link 10/2022 - 03/2021
2	tisagenlecleucelIBA 10/2022 - 03/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2021
2	NivolumabIBA 09/2021 - 03/2021
2	Alemtuzumab (Campath)FDA Link 03/2021 - 08/2017
2	Abatacept (Orencia)FDA Link 03/2021 - 08/2017
2	IpilimumabIBA 03/2021 - 08/2017
2	Basiliximab FDA Link 03/2021 - 08/2017
2	AntibodiesIBA 01/2021 - 09/2016
2	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2020 - 02/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2018
2	EchinocandinsIBA 09/2018 - 02/2017
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 04/2017
2	CytokinesIBA 04/2017 - 08/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013 - 05/2011
1	Apolipoproteins E (ApoE)IBA 03/2024
1	ApolipoproteinsIBA 03/2024
1	LipidsIBA 03/2024
1	Asparaginase (Elspar)FDA Link 03/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024
1	molnupiravirIBA 10/2023
1	Antiviral Agents (Antivirals)IBA 10/2023
1	nirmatrelvir and ritonavir drug combinationIBA 10/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2023
1	galactomannanIBA 01/2023
1	LithostathineIBA 01/2023
1	proadrenomedullinIBA 01/2023
1	Bortezomib (Velcade)FDA Link 10/2022
1	venetoclaxIBA 10/2022
1	Complement System Proteins (Complement)IBA 06/2022
1	eculizumab FDA Link 01/2022
1	Alefacept (Amevive)FDA Link 03/2021
1	ibritumomab tiuxetan (Zevalin)FDA Link 03/2021
1	durvalumabIBA 03/2021
1	combotoxIBA 03/2021
1	avelumabIBA 03/2021

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2023 - 07/2009
7	Therapeutics 04/2024 - 08/2017
5	Hematopoietic Stem Cell Transplantation 01/2023 - 07/2009
4	Catheters 01/2023 - 05/2010
2	Cell Transplantation 01/2023 - 12/2020
1	Critical Care (Surgical Intensive Care) 01/2022
1	Artificial Respiration (Mechanical Ventilation) 03/2021